TCP
SGYP

Tourbillon Capital Partners’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Tourbillon Capital Partners’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-4,147,254
Closed -$18.5M – 82
2017
Q2 		$18.5M Buy
+4,147,254
New +$17.1M 0.36% 50
2016
Q1 		– Sell
-980,931
Closed -$5.56M – 95
2015
Q4 		$5.56M Buy
980,931
+8,194
+0.8% +$50K 0.12% 70
2015
Q3 		$5.16M Buy
972,737
+504,937
+108% +$3.91M 0.14% 82
2015
Q2 		$3.88M Buy
+467,800
New +$2.27M 0.08% 94

Other funds holding SGYP

PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Tourbillon Capital Partners's SGYP Position: Q3 2017 in Review

Tourbillon Capital Partners sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q3 2017, closing a stake of 4,147,254 shares — an estimated $18.5M sold.

Tourbillon Capital Partners first reported a position in SGYP in Q2 2015 and held it in 4 quarters. The position peaked at $18.5M in Q2 2017. 143 funds tracked by Wall St. Rank hold SGYP as of Q3 2017.

  • Tourbillon Capital Partners reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q3 2017 after selling out during the quarter.
  • Tourbillon Capital Partners sold 4,147,254 Synergy Pharmaceuticals, Inc Common Stock shares in Q3 2017, an estimated $18.5M.
  • Tourbillon Capital Partners first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2015 and held it in 4 quarters.
  • Tourbillon Capital Partners's Synergy Pharmaceuticals, Inc Common Stock position peaked at $18.5M in Q2 2017.
  • 143 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q3 2017.

Based on Tourbillon Capital Partners's 13F filing for Q3 2017, filed 14 Nov 2017.